UB faculty members Glenna Bett and Randall Rasmusson are among
the latest wave of entrepreneurs flooding START-UP NY, making our
region the leader with at least 42 companies. Their company -
CytoCybernetics - is developing technology that would make
prescription drugs safer.
Doctors get a better look at your insides when you drink
'Nanojuice' combined with laser light. This can help in identifying
and treating gastrointestinal ailments such as irrritable bowel
syndrome, celiac's disease, and Crohn's disease.
SUNY Distinguished Professor Paras Prasad made sure his
groundbreaking research went to work. A world leader in
nanomedicine, he licensed his technologies to UB spinoff
Nanobiotix, now a publicly traded company based in France. The
results earned him UB's first Innovation Impact Award.
The National Cancer Institute awarded For-Robin, a UB spinoff
company, $2 million to continue developing a potential treatment
for breast and other types of cancer. Area leaders say the benefits
extend beyond the medical to the importance of these young
companies in growing WNY's life sciences economy.